Fara R. Berkowitz, R.Ph, Pharm.D
Senior Director Investor Relations and Corporate Development

Fara R Berkowitz has served as Senior Director Investor Relations and Corporate Development of Neothetics since September 2015 and consultant since January 2013. Fara brings over 15 years in the healthcare industry spanning clinical practice, financing, and investing. Prior to joining, Fara was a Managing Director at Meadowvale Partners Capital Management, where she invested in public life science companies. Before Meadowvale, she was an analyst at Sivik Global Healthcare, where she was responsible for investments in biotechnology as well as specialty and generic pharmaceuticals. Additionally Fara served as an Equity Research Analyst at Goldman Sachs where she initiated coverage on the generic pharmaceutical sector, as well as individual specialty pharmaceutical companies. At Goldman, she worked with capital markets on IPOs, secondary offerings and debt offerings and was selected by senior management to participate in the Goldman Sachs Women’s Career Strategic Initiative program. Fara holds her MBA and Certificate in Healthcare Management from Duke University and her Doctor of Pharmacy and B.S. from Rutgers College of Pharmacy.
[Back to Management]